Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
60.83
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 11, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Thera
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Today 4:15 EDT
An investment in these players today could score a big win down the road.
Via
The Motley Fool
Why Viking Therapeutics Stock Rocked the Market Today
September 11, 2024
The biotech continued to get attention from both pundits and investors, thanks largely to its investigational obesity drug.
Via
The Motley Fool
Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan
September 11, 2024
JPMorgan analyst Hardik Parikh initiated coverage on Viking Therapeutics with an Overweight rating and a December 2025 price target of $80.
Via
Benzinga
Viking Therapeutics Unusual Options Activity For September 11
September 11, 2024
Via
Benzinga
Novo Nordisk Jumps After New Weight-Loss Pill Tops Wegovy; Eli Lilly, Viking Shares Rise
September 11, 2024
The company is working on a drug that targets GLP-1 and amylin to improve weight loss.
Via
Investor's Business Daily
Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?
September 07, 2024
The huge demand for effective new weight management drugs has billionaire investors feeling bullish about this stock.
Via
The Motley Fool
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $7,500 Today
September 06, 2024
Via
Benzinga
(VKTX) - Analyzing Viking Therapeutics's Short Interest
August 21, 2024
Via
Benzinga
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
September 05, 2024
Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation. Other drugs also affected.
Via
Benzinga
Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year
September 05, 2024
Nvidia is heading for a 118% gain this year.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
Via
Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
September 03, 2024
This business has solid results in hand, lots of cash, and more catalysts coming.
Via
The Motley Fool
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
August 29, 2024
The race to develop the next big obesity treatment is on with leaders Lilly and Novo trying to keep their top slots.
Via
Investor's Business Daily
Unpacking the Latest Options Trading Trends in Viking Therapeutics
August 20, 2024
Via
Benzinga
$100 Invested In This Stock 5 Years Ago Would Be Worth $800 Today
August 19, 2024
Via
Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
August 05, 2024
Via
Benzinga
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
August 29, 2024
Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC.
Via
Benzinga
Why Viking Therapeutics Stock Got Thrashed on Tuesday
August 27, 2024
A monster rival is making aggressive moves in one particular segment.
Via
The Motley Fool
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
August 27, 2024
The single-dose vials will also increase supply, the drug giant says.
Via
Investor's Business Daily
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
August 26, 2024
The companies are chasing major innovations.
Via
The Motley Fool
Viking Therapeutics Stock Could Rocket 76% Higher According to Wall Street. Is It a Buy Now?
August 26, 2024
The new drugs this company is developing could be worth a lot more than the present market value of its stock.
Via
The Motley Fool
Big Pharma Stocks: Who’s Leading The Race And Who’s Slipping?
August 20, 2024
Merck's wider drug moat and acquisition spree makes it a safer bet but VKTX can be the next LLY.
Via
Talk Markets
Could Viking Therapeutics Become the Next Novo Nordisk?
August 17, 2024
Given this biotech's ascent, its odds of becoming a giant are better than most.
Via
The Motley Fool
3 Promising Biotech Stocks for the Long-Term: August 2024
August 13, 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2024
Via
Benzinga
Prediction: Buying Biotech and Pharma Stocks During This Sell-Off Will Be a Smart Move
August 12, 2024
There isn't much to suggest these businesses are actually vulnerable.
Via
The Motley Fool
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
News from a competitor gave investors an unwelcome dose of reality.
Via
The Motley Fool
3 Unstoppable Stocks to Buy in August
August 03, 2024
It's not hard to envision how all three of these stocks can deliver exceptional growth.
Via
The Motley Fool
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
August 02, 2024
The popularity surrounding weight loss drugs such as Mounjaro and Ozempic has brought Eli Lilly and Novo Nordisk newfound growth.
Via
The Motley Fool
What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks.
August 01, 2024
Anti-obesity therapeutics are all the rage and for good reason. Investors seeking to profit should consider these weight loss stocks.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
17
18
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.